newsfilter
← Latest News
GlobeNewswire·

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing

MILAN and NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ:GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that it has strengthened its partnership